These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10728041)

  • 1. Immunogenicity of recombinant hepatitis B vaccine in thalassemic children.
    Sethi GR; Sharma S; Sudha S; Rishi RK
    Indian Pediatr; 1999 May; 36(5):498-501. PubMed ID: 10728041
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological response to hepatitis B vaccine in polytransfused thalassemic patients.
    Alavian SM; Tabatabaei SV
    Pediatr Hematol Oncol; 2010 May; 27(4):324-5; author reply 326-7. PubMed ID: 20426525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule.
    Gomber S; Sharma R; Ramachandran VG; Talwar V; Singh B
    Indian Pediatr; 2000 Apr; 37(4):411-3. PubMed ID: 10781235
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report.
    But DY; Lai CL; Lim WL; Fung J; Wong DK; Yuen MF
    Vaccine; 2008 Dec; 26(51):6587-91. PubMed ID: 18835318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
    Rao MN; Joshi N; Habibullah CM
    Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic response to hepatitis B vaccination in children with isolated anti-Hbc.
    Atabek ME; Erkul I
    J Trop Pediatr; 2006 Feb; 52(1):71-2. PubMed ID: 15917263
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru].
    Lozano M A; Caycho O J; Antunez de Mayolo A; Vera D; Posadas R D
    Rev Gastroenterol Peru; 2003; 23(4):259-64. PubMed ID: 14716420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
    Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
    Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.